avian pancreatic polypeptide
Recently Published Documents


TOTAL DOCUMENTS

77
(FIVE YEARS 0)

H-INDEX

25
(FIVE YEARS 0)

2008 ◽  
Vol 108 (5) ◽  
pp. 1017-1021 ◽  
Author(s):  
Marcus P. D. Hatfield ◽  
Nicholas Y. Palermo ◽  
József Csontos ◽  
Richard F. Murphy ◽  
Sándor Lovas

2007 ◽  
Vol 67 (4) ◽  
pp. 735-740 ◽  
Author(s):  
AA Nascimento ◽  
A Sales ◽  
TRD Cardoso ◽  
NL Pinheiro ◽  
RMM Mendes

In the present study, we investigated types of pancreatic endocrine cells and its respective peptides in the Brazilian sparrow species using immunocytochemistry. The use of polyclonal specific antisera for somatostatin, glucagon, avian pancreatic polypeptide (APP), YY polypeptide (PYY) and insulin, revealed a diversified distribution in the pancreas. All these types of immunoreactive cells were observed in the pancreas with different amounts. Insulin- Immunoreactive cells to (B cells) were most numerous, preferably occupying the central place in the pancreatic islets. Somatostatin, PPA, PYY and glucagon immunoreactive cells occurred in a lower frequency in the periphery of pancreatic islets.


2006 ◽  
Vol 118 (38) ◽  
pp. 6445-6448 ◽  
Author(s):  
Simon Jurt ◽  
Andreas Aemissegger ◽  
Peter Güntert ◽  
Oliver Zerbe ◽  
Donald Hilvert

2006 ◽  
Vol 45 (38) ◽  
pp. 6297-6300 ◽  
Author(s):  
Simon Jurt ◽  
Andreas Aemissegger ◽  
Peter Güntert ◽  
Oliver Zerbe ◽  
Donald Hilvert

2004 ◽  
Vol 78 (12) ◽  
pp. 6657-6665 ◽  
Author(s):  
Nobuhisa Shimba ◽  
Anson M. Nomura ◽  
Alan B. Marnett ◽  
Charles S. Craik

ABSTRACT Kaposi's sarcoma-associated herpesvirus (KSHV), like all herpesviruses, encodes a protease (KSHV Pr), which is necessary for the viral lytic cycle. Herpesvirus proteases function as obligate dimers; however, each monomer has an intact, complete active site which does not interact directly with the other monomer across the dimer interface. Protein grafting of an interfacial KSHV Pr α-helix onto a small stable protein, avian pancreatic polypeptide, generated a helical 30-amino-acid peptide designed to disrupt the dimerization of KSHV Pr. The chimeric peptide was optimized through protein modeling of the KSHV Pr-peptide complex. Circular dichroism analysis and gel filtration chromatography revealed that the rationally designed peptide adopts a helical conformation and is capable of disrupting KSHV Pr dimerization, respectively. Additionally, the optimized peptide inhibits KSHV Pr activity by 50% at a ∼200-fold molar excess of peptide to KSHV Pr, and the dissociation constant was estimated to be 300 μM. Mutagenesis of the interfacial residue M197 to a leucine resulted in an inhibitory concentration which was twofold higher for KSHV Pr M197L than for KSHV Pr, in agreement with the model that the dimer interface is involved in peptide binding. These results indicate that the dimer interface, as well as the active sites, of herpesvirus proteases is a viable target for inhibiting enzyme activity.


Sign in / Sign up

Export Citation Format

Share Document